The mechanism of bifonazole-induced [Ca2+]i rises and non-Ca2+-triggered cell death in PC3 human prostate cancer cells. (December 2014)
- Record Type:
- Journal Article
- Title:
- The mechanism of bifonazole-induced [Ca2+]i rises and non-Ca2+-triggered cell death in PC3 human prostate cancer cells. (December 2014)
- Main Title:
- The mechanism of bifonazole-induced [Ca2+]i rises and non-Ca2+-triggered cell death in PC3 human prostate cancer cells
- Authors:
- Cheng, Jin Shiung
Chou, Chiang-Ting
Liang, Wei-Zhe
Kuo, Chun-Chi
Shieh, Pochuen
Kuo, Daih-Huang
Jan, Chung-Ren - Abstract:
- <abstract> <title>Abstract</title> <p>Bifonazole is an antifungal drug widely used for treating skin diseases. The effect of bifonazole on physiology of cancer cells is unclear. The effect of bifonazole on cytosolic free Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) and viability in PC3 human prostate cancer cells was explored. The Ca<sup>2+</sup>-sensitive fluorescent dye, fura-2, was applied to measure [Ca<sup>2+</sup>]<sub>i</sub>. Bifonazole at concentrations of 5–30 µM induced a [Ca<sup>2+</sup>]<sub>i</sub> rise in a concentration-dependent manner. The response was reduced by 50% by removing extracellular Ca<sup>2+</sup>. Bifonazole-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise was not altered by nifedipine, econazole, SK&amp;F96365 and protein kinase C activator, but was inhibited by 75% by GF109203X, a protein kinase C inhibitor. In Ca<sup>2+</sup>-free medium, treatment with the endoplasmic reticulum Ca<sup>2+</sup> pump inhibitor 2, 5-di-tert-butylhydroquinone (BHQ) nearly abolished bifonazole-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Conversely, treatment with bifonazole abolished BHQ-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Inhibition of phospholipase C with U73122 abolished bifonazole-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. At 30–100 µM, bifonazole decreased cell viability concentration-dependently, which was not reversed by chelating cytosolic Ca<sup>2+</sup> with 1, 2-bis(2-aminophenoxy)ethane-N, N, N″, N′-tetraacetic acid/acetoxy methyl.<abstract> <title>Abstract</title> <p>Bifonazole is an antifungal drug widely used for treating skin diseases. The effect of bifonazole on physiology of cancer cells is unclear. The effect of bifonazole on cytosolic free Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) and viability in PC3 human prostate cancer cells was explored. The Ca<sup>2+</sup>-sensitive fluorescent dye, fura-2, was applied to measure [Ca<sup>2+</sup>]<sub>i</sub>. Bifonazole at concentrations of 5–30 µM induced a [Ca<sup>2+</sup>]<sub>i</sub> rise in a concentration-dependent manner. The response was reduced by 50% by removing extracellular Ca<sup>2+</sup>. Bifonazole-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise was not altered by nifedipine, econazole, SK&amp;F96365 and protein kinase C activator, but was inhibited by 75% by GF109203X, a protein kinase C inhibitor. In Ca<sup>2+</sup>-free medium, treatment with the endoplasmic reticulum Ca<sup>2+</sup> pump inhibitor 2, 5-di-tert-butylhydroquinone (BHQ) nearly abolished bifonazole-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Conversely, treatment with bifonazole abolished BHQ-evoked [Ca<sup>2+</sup>]<sub>i</sub> rise. Inhibition of phospholipase C with U73122 abolished bifonazole-induced [Ca<sup>2+</sup>]<sub>i</sub> rise. At 30–100 µM, bifonazole decreased cell viability concentration-dependently, which was not reversed by chelating cytosolic Ca<sup>2+</sup> with 1, 2-bis(2-aminophenoxy)ethane-N, N, N″, N′-tetraacetic acid/acetoxy methyl. Annexin V/propidium iodide staining data suggest that bifonazole (30–100 µM) induced apoptosis concentration-dependently. Together, in PC3 human prostate cancer cells, bifonazole induced [Ca<sup>2+</sup>]<sub>i</sub> rises by inducing phospholipase C- and protein kinase C-dependent Ca<sup>2+</sup> release from the endoplasmic reticulum and Ca<sup>2+</sup> influx <italic>via</italic> non-store-operated pathways. Bifonazole induced cell death that might involve apoptosis.</p> </abstract> … (more)
- Is Part Of:
- Journal of receptor and signal transduction research. Volume 34:Number 6(2014)
- Journal:
- Journal of receptor and signal transduction research
- Issue:
- Volume 34:Number 6(2014)
- Issue Display:
- Volume 34, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 34
- Issue:
- 6
- Issue Sort Value:
- 2014-0034-0006-0000
- Page Start:
- 493
- Page End:
- 499
- Publication Date:
- 2014-12
- Subjects:
- Cell receptors -- Periodicals
Cellular signal transduction -- Periodicals
571.6 - Journal URLs:
- http://informahealthcare.com/journal/rst ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/10799893.2014.921201 ↗
- Languages:
- English
- ISSNs:
- 1079-9893
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5047.849000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3254.xml